Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective.

Molecules (Basel, Switzerland) - 8 Apr 2015

Miftahussurur Muhammad, Yamaoka Yoshio

Abstract excerpt

Asia has the largest population of any continent and the highest incidence of gastric cancer in the world, making it very important in the context of Helicobacter pylori infection. According to current guidelines, standard triple therapy containing a proton pump inhibitor (PPI) and two antibiotics; amoxicillin (AMX) and clarithromycin (CAM) or metronidazole (MNZ), is still the preferred first-line regimen for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Asia
Share to Cytochrome P-450 CYP2C19

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Bacterial

Share to Helicobacter Infections

Share to Helicobacter pylori

Share to Proton Pump Inhibitors

Share to Stomach Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 25856059
DOI: 10.3390/molecules20046068
PMCID: PMC6272313

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective.PMID 25856059Read ↗

Treatment of Helicobacter pylori infection: Where are we now?Semantic proximity Read ↗

Treatment of Helicobacter pylori infection: meeting the challenge of antimicrobial resistance.Semantic proximity Read ↗

High antibiotic resistance rate: A difficult issue for Helicobacter pylori eradication treatment.Semantic proximity Read ↗

Epidemiology and pattern of antibiotic resistance in Helicobacter pylori: scenario from Saudi Arabia.Semantic proximity Read ↗

Antibiotic resistance in Helicobacter pylori : From potential biomolecular mechanisms to clinical practiceSemantic proximity Read ↗

Mutation-driven mechanisms underlying antibiotic resistance of Helicobacter pylori in Asia: A systematic review and meta-analysis (2000-2024).Semantic proximity Read ↗

Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance.Semantic proximity Read ↗

Importance of antimicrobial susceptibility testing for the management of eradication in Helicobacter pylori infection.Semantic proximity Read ↗

Factors affecting first-line triple therapy of Helicobacter pylori including CYP2C19 genotype and antibiotic resistance.Semantic proximity Read ↗

Molecular Detection of Antibiotic-Resistant Helicobacter pylori.Semantic proximity Read ↗

Current and future insights in H. pylori eradication regimens: the need of tailoring therapy.Semantic proximity Read ↗

Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.